Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Ingevity's share price for the quarter that ended in Mar. 2026 was €59.15. Ingevity's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 35 Mil. Therefore, Ingevity's market cap for the quarter that ended in Mar. 2026 was €2,064 Mil.
Ingevity's quarterly market cap
increased
from Sep. 2025 (€1,600 Mil) to Dec. 2025 (€1,774 Mil) and
increased
from Dec. 2025 (€1,774 Mil) to Mar. 2026 (€2,064 Mil).
Ingevity's annual market cap
declined
from Dec. 2023 (€1,551 Mil) to Dec. 2024 (€1,399 Mil) but then
increased
from Dec. 2024 (€1,399 Mil) to Dec. 2025 (€1,774 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Ingevity's Enterprise Value for Today is €3,269 Mil.
Ingevity (FRA:IGX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Ingevity Market Cap Related Terms
Ingevity Market Cap Historical Data
* Premium members only.
The historical data trend for Ingevity's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Ingevity's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ingevity Market Cap vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Ingevity's Market Cap distribution charts can be found below:
* The bar in red indicates where Ingevity's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Ingevity's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ingevity (FRA:IGX) has a Market Cap of €2,259 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Ingevity and its competitors. According to the industry distribution chart, Ingevity ranks #206 out of 1634 companies in the Chemicals industry, placing it in the top 12.6%.
Is Ingevity's Market Cap too high?
Ingevity's current Market Cap is €2,259 Mil. Based on the distribution chart, Ingevity ranks #206 out of 1634 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Ingevity has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Ingevity's Market Cap compare to KWR and MTX?
According to the Chemicals industry distribution chart, Ingevity ranks #206 out of 1634 companies for Market Cap. This places Ingevity in the top 13% of its industry — outperforming the majority of peers. The industry median Market Cap is 293.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Chemicals company?
The median Market Cap among Chemicals companies is 293.51, based on 1,634 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Ingevity and its competitors. For the Chemicals industry, the median Market Cap is 293.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ingevity's current Market Cap is €2,259 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ingevity stock overvalued right now?
Ingevity (FRA:IGX) has a current Market Cap of €2,259 Mil. The stock's GF Value™ is €37.59, compared to a current price of €62.00 — trading 64.9% above its estimated fair value. The current Market Cap is €2,259 Mil. Ingevity's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Ingevity (FRA:IGX), the current Market Cap is €2,259 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ingevity (FRA:IGX) Overvalued in 2026?
Based on GuruFocus' analysis, Ingevity stock appears to be overvalued.
The current stock price of €62.00 is trading 64.9% above its estimated GF Value™ of €37.59.
Key valuation signals for FRA:IGX:
Market Cap: €2,259 Mil
GF Value™: €37.59 vs. price of €62.00 (64.9% above fair value)
No single metric tells the full story. See the FRA:IGX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.
65GF Score
Get the complete analysis for FRA:IGX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:IGX has been successfully added to your 
